Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial

Part of paid clinical trials in Chicago, Illinois.

Sponsor
Northwestern University
Study ID
NCT07632742
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
MALE
Age
18 Years - 100 Years
Healthy Volunteers
Accepted

Interventions

  • Magneto 150 holmium laser — DEVICE
    The HoLEP procedure will be performed using the Quanta Magneto 150 holmium laser
  • Moses 2.0 holmium laser — DEVICE
    The HoLEP procedure will be performed using the Moses 2.0 holmium laser

Study Details

The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.

Key Dates

Start date
Jun 30, 2026
Status verified
Apr 2026
Primary completion
Jun 30, 2027
Completion
Jun 30, 2028

Study Design

Enrollment
180 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Moses 2.0
    HoLEP procedure performed using the Moses 2.0 holmium laser
  • Experimental: Magneto 150
    HoLEP procedure performed using Magneto 150 holmium laser

Primary Outcome Measure

Mean hemostasis time [ Time Frame: During surgery ]

Central Contacts

Locations (1)

FacilityCityStateZIP
Northwestern UniversityChicagoIllinois60611

Find similar trials in Chicago, IL

By research site
Northwestern University· Chicago, IL

Related Studies